You have 9 free searches left this month | for more free features.

TDF:Tenofovir, Urine beta2microglobulin

Showing 1 - 25 of 5,725

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for

Recruiting
  • Surgery-Complications
  • +2 more
    • Wonju, Gangwon, Korea, Republic of
      Wonju Severance Christian Hospital
    Aug 9, 2022

    Kidney Function Through Combination of Renal Biomarkers in Blood

    Completed
    • Renal Biomarkers in Children
    • blood test for renal biomarkers (creatinine, cystatin C, Neutrophil gelatinase-associated lipocalin, beta-trace protein, beta-2 microglobulin, uromodulin)
    • urine test for renal biomarkers (creatinine, cystatin C, Neutrophil gelatinase-associated lipocalin, beta-trace protein beta-2 microglobulin, uromodulin, albumin)
    • Basel, Switzerland
      University of Basel Children's Hospital
    Jul 13, 2020

    HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

    Completed
    • HIV Infections
    • DTG + 3TC
    • TAF based regimen (TBR)
    • Phoenix, Arizona
    • +132 more
    Jun 27, 2022

    Pre-Exposure Prophylaxis of HIV-1 Infection Trial in Worldwide (F/TAF, F/TDF, F/TAF Placebo)

    Active, not recruiting
    • Pre-Exposure Prophylaxis of HIV-1 Infection
    • Beverly Hills, California
    • +92 more
    Jun 28, 2022

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil

    Active, not recruiting
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Dolutegravir (DTG)
    • +2 more
    • Phoenix, Arizona
    • +89 more
    Jun 27, 2022

    Chronic Hepatitis b Trial in Seoul (Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate)

    Completed
    • Chronic Hepatitis b
    • Tenofovir Alafenamide
    • Tenofovir Disoproxil Fumarate
    • Seoul, Korea, Republic of
      Asan Medical Center
    Mar 25, 2021

    Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

    Completed
    • Human Immunodeficiency Virus Type 1
    • Phoenix, Arizona
    • +81 more
    Nov 25, 2021

    Risk Reduction Trial in Thika (PUMA)

    Active, not recruiting
    • Risk Reduction
    • PUMA
    • Thika, Near Nairobi, Kenya
      KEMRI Partners in Health and Research Development (PHRD), Thika
    Jan 11, 2023

    Acute Kidney Injury Trial in Singapore (AKI risk screening using RenaFAST POCT test kits)

    Recruiting
    • Acute Kidney Injury
    • AKI risk screening using RenaFAST POCT test kits
    • Singapore, Singapore
      National University Hospital
    Nov 6, 2023

    Renal Insufficiency, Tenofovir Trial in Bangkok Noi (Switching to Tenofovir Alafenamide)

    Recruiting
    • Renal Insufficiency
    • Tenofovir
    • Switching to Tenofovir Alafenamide
    • Bangkok Noi, Bangkok, Thailand
      Faculty of Medicine Siriraj Hospital, Mahidol University
    Mar 7, 2022

    Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

    Completed
    • Medication Adherence
    • HIV
    • dolutegravir oral tablet 50mg
    • +3 more
    • Pittsburgh, Pennsylvania
      HIV/AIDS Clinical Research Unit / University of Pittsburgh
    Mar 2, 2022

    Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF

    Completed
    • Hepatitis C
    • HIV Coinfection
    • TDF with a boosted protease inhibitor
    • +2 more
    • Aurora, Colorado
      University of Colorado Hospital
    Jan 21, 2021

    Chronic Hepatitis b, Tenofovir Alafenamide Fumarate Trial in Hangzhou (Tenofovir Alafenamide Tablets)

    Recruiting
    • Chronic Hepatitis b
    • Tenofovir Alafenamide Fumarate
    • Tenofovir Alafenamide Tablets
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    May 8, 2023

    Nephrolithiasis Trial in New York (Thulium Fibre Laser, Holmium:Yttrium-Aluminum-Garnet)

    Recruiting
    • Nephrolithiasis
    • Thulium Fibre Laser
    • Holmium:Yttrium-Aluminum-Garnet
    • New York, New York
      Mount Sinai West
    Apr 22, 2022

    AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))

    Not yet recruiting
    • Acquired Immunodeficiency Syndrome
    • Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG)
    • (no location specified)
    Aug 6, 2022

    HIV/AIDS Trial in Paris, Chiang Mai (TDF/FTC 300mg/200mg fixed-dose combination tablets, TAF/FTC 25mg/200mg fixed-dose

    Not yet recruiting
    • HIV/AIDS
    • TDF/FTC 300mg/200mg fixed-dose combination tablets
    • TAF/FTC 25mg/200mg fixed-dose combination tablets
    • Paris, France
    • +1 more
    Apr 3, 2023

    Risk Reduction Trial in Cape Town (UTRA, UTRA feedback)

    Recruiting
    • Risk Reduction
    • UTRA
    • UTRA feedback
    • Cape Town, Western Cape, South Africa
      Desmond Tutu Health Foundation, University of Cape Town
    May 17, 2022

    Human Immunodeficiency Virus Trial in Atlanta (TDF/FTC Dose Schedule for Arm A, TDF/FTC Dose Schedule for Arm B)

    Completed
    • Human Immunodeficiency Virus
    • TDF/FTC Dose Schedule for Arm A
    • TDF/FTC Dose Schedule for Arm B
    • Atlanta, Georgia
      Hope Clinic
    Sep 20, 2022

    HIV, Fatty Liver Disease Trial in Madrid (Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil

    Recruiting
    • HIV Infections
    • Fatty Liver Disease
    • Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day
    • +2 more
    • Madrid, Spain
    • +3 more
    Jun 13, 2023

    HIV, Weight Gain Trial in Helsinki (gastroscopy)

    Not yet recruiting
    • HIV Infections
    • Weight Gain
    • gastroscopy
    • Helsinki, Uusimaa, Finland
      Infectious Disease Clinic, Helsinki University Hospital
    Apr 6, 2022

    Hiv Trial in Philadelphia (FTC/TAF)

    Completed
    • Hiv
    • Philadelphia, Pennsylvania
      Philadelphia FIGHT
    Sep 29, 2021

    HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)

    Not yet recruiting
    • HIV Infections
    • Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
    • Paris, Ile De France, France
      Christine Katlama
    Jul 26, 2022

    HIV Prevention Trial in Brazil, United States (Immediate Intervention Arm Truvada in the US, Deferred Intervention Arm Truvada

    Enrolling by invitation
    • HIV Prevention
    • Immediate Intervention Arm Truvada in the US
    • +5 more
    • San Francisco, California
    • +4 more
    Aug 30, 2022

    Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

    Not yet recruiting
    • Patient Satisfaction
    • +3 more
    • tenofovir alafenamide (TAF)
    • (no location specified)
    Oct 15, 2022